Metagenomi Therapeutics (MGX) Non-Current Deffered Revenue (2023 - 2026)
Metagenomi Therapeutics (MGX) recorded Non-Current Deffered Revenue of $1.64 million in Q1 2026, down 62.6% from $4.37 million a year earlier and down 45.3% from the prior quarter.
Powered by 
Analysis
Metagenomi Therapeutics (MGX) Non-Current Deffered Revenue (2023 - 2026) Analysis & Trends
At the end of FY2025, Metagenomi Therapeutics reported Non-Current Deffered Revenue of $2.99 million, down 70.8% from FY2024.
- Across earlier years, Non-Current Deffered Revenue came in at $10.24 million in FY2024 (-66.9%) and $30.93 million in FY2023.
- The Q1 2026 figure is the lowest quarterly Non-Current Deffered Revenue in data going back to Q4 2023.
- On a year-over-year basis, Non-Current Deffered Revenue has declined for six consecutive quarters, with an average decline of 73.8% over the last six quarters.
- Per Business Quant, the preceding three quarters came in at $2.99 million (Q4 2025), $1.9 million (Q3 2025) and $3.55 million (Q2 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Deffered Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,144.36 Bn | 1,112.95 Bn | 19.71 Bn | - |
| 2 | Johnson & Johnson | 635.36 Bn | 555.22 Bn | 17.30 Bn | - |
| 3 | AbbVie | 502.79 Bn | 475.90 Bn | 12.70 Bn | - |
| 4 | Merck | 356.08 Bn | 310.46 Bn | 12.21 Bn | - |
| 5 | Novartis Ag | 300.87 Bn | 264.86 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 264.31 Bn | 237.99 Bn | 12.86 Bn | - |
| 7 | Amgen | 239.07 Bn | 194.47 Bn | 7.24 Bn | - |
| 8 | Gilead Sciences | 194.50 Bn | 168.70 Bn | 6.22 Bn | - |
| 9 | Pfizer | 171.00 Bn | 117.64 Bn | 10.94 Bn | - |
| 10 | Metagenomi Therapeutics | 29.94 Mn | -575.80 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | 1.64 Mn |
| Dec 31, 2025 | 2.99 Mn |
| Sep 30, 2025 | 1.90 Mn |
| Jun 30, 2025 | 3.55 Mn |
| Mar 31, 2025 | 4.37 Mn |
| Dec 31, 2024 | 10.24 Mn |
| Sep 30, 2024 | 12.43 Mn |
| Jun 30, 2024 | 17.33 Mn |
| Mar 31, 2024 | 20.31 Mn |
| Dec 31, 2023 | 30.93 Mn |
API Access
Metagenomi Therapeutics Non-Current Deffered Revenue API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-current-deffered-revenue&ticker=MGX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-current-deffered-revenue", "ticker": "MGX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-current-deffered-revenue&ticker=MGX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();